Navigating Heterogeneity in Generalized Anxiety Disorder to Successfully Develop a Subtype-Selective Monotherapy Treatment
Time: 1:45 pm
day: Day One Track B PM
Details:
- Dealing with comorbidities and overlapping indications when recruiting an appropriate clinical population
- Determining which patients will be most responsive to a given anxiolytic therapy
- Accounting for fluctuations in anxiety levels in individual patients throughout the trial
